KLF6 and prostate carcinoma: Re-expression of wild type KLF6 into prostate carcinoma PC-3 cells and non-small lung cancer cells, which harbor loss-of-function mutations or downregulation of the endogenous klf6 gene, respectively, enhanced growth suppression and apoptosis [29], [15].